» Articles » PMID: 39478503

Endometriosis Development in Relation to Hypoxia: a Murine Model Study

Overview
Journal Mol Med
Publisher Biomed Central
Date 2024 Oct 31
PMID 39478503
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endometriosis, due to its ambiguous symptoms, still remains one of the most difficult female diseases to treat, with an average diagnosis time of 7-9 years. The changing level of hypoxia plays an important role in a healthy endometrium during menstruation and an elevated expression of the hypoxia-inducible factor 1-alpha (HIF-1α) has been demonstrated in ectopic endometria. HIF-1α mediates the induction of proangiogenic factors and the development of angiogenesis is a critical step in the establishment and pathogenesis of endometriosis. Although the inhibition of angiogenesis has been proposed as one of the actionable therapeutic modalities, vascular normalization and re-oxygenation may become a possible new approach for therapeutic intervention.

Methods: Our goal was to investigate whether a selected murine model of endometriosis would be suitable for future studies on new methods for treating endometriosis. Non-invasive, high-resolution ultrasound-monitored observation was selected as the preclinical approach to obtain imaging of the presence and volume of the endometriotic-like lesions. The EF5 (2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide) compound that selectively binds to reduced proteins in hypoxic cells was used for hypoxia detection. The expression of Pten and other crucial genes linking endometriosis and hypoxia were also assessed.

Results: Using EF5, a pentafluorinated derivative of the 2-nitroimidazole that is metabolically reduced by oxygen-inhibitable nitroreductase, we confirmed that hypoxia did develop in the selected model and was detected in uterine and ectopic endometriotic lesions. Moreover, the changes in oxygen tension also influenced the expression level of significant genes related to endometriosis, like Pten, Trp53, Hif1a, Epas1, and Vegfa. Their strong modulation evidenced here is indicative of model reliability. Using high-resolution ultrasound-based imaging, we present a non-invasive method of visualization that enables the detection and observation of lesion evolution throughout the duration of the experiment, which is fundamental for further preclinical studies and treatment evaluation.

Conclusions: The selected model and method of visualization appear to be suitable for the study of new treatment strategies based on hypoxia alleviation and blood flow restoration.

References
1.
Klauber N, Rohan R, Flynn E, DAmato R . Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med. 1997; 3(4):443-6. DOI: 10.1038/nm0497-443. View

2.
Byers S, Wiles M, Dunn S, Taft R . Mouse estrous cycle identification tool and images. PLoS One. 2012; 7(4):e35538. PMC: 3325956. DOI: 10.1371/journal.pone.0035538. View

3.
McLaren J, Prentice A, Charnock-Jones D, Smith S . Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 1996; 11(1):220-3. DOI: 10.1093/oxfordjournals.humrep.a019023. View

4.
Donnez J, Smoes P, Gillerot S, Nisolle M . Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod. 1998; 13(6):1686-90. DOI: 10.1093/humrep/13.6.1686. View

5.
Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C . Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011; 15(6):1239-53. PMC: 4373326. DOI: 10.1111/j.1582-4934.2011.01258.x. View